These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26876001)

  • 1. Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
    J Dermatol; 2016 Jul; 43(7):808-10. PubMed ID: 26876001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.
    Dall'Ara F; Lazzaroni MG; Antonioli CM; Airò P
    Rheumatol Int; 2017 May; 37(5):847-851. PubMed ID: 28160072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis.
    Lazzaroni MG; Campochiaro C; Bertoldo E; De Luca G; Caimmi C; Tincani A; Franceschini F; Airò P
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):25-28. PubMed ID: 33337991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
    Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
    Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
    Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
    Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
    Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
    Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis.
    Sobanski V; Dauchet L; Lefèvre G; Lambert M; Morell-Dubois S; Sy T; Hachulla E; Hatron PY; Launay D; Dubucquoi S
    Arthritis Rheumatol; 2014 Feb; 66(2):407-17. PubMed ID: 24504813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
    Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
    Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
    Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
    J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
    Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
    Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
    Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
    J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
    Yayla ME; İlgen U; Düzgün N
    Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
    Kuwana M; Kimura K; Kawakami Y
    Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.